Cutler Group’s iBio IBIO Stock Holding History

Cutler Group’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-111	Closed	-$3K	–	5677
2021 Q3	$3K	Sell	111 -127	-53%	-$79.1K	﹤0.01%	4814
2021 Q2	$10K	Buy	238 +188	+376%	+$137K	﹤0.01%	3901
2021 Q1	$7K	Sell	50 -14	-22%	-$12.2K	﹤0.01%	4106
2020 Q4	$6K	Buy	64 +48	+300%	+$39.1K	﹤0.01%	3527
2020 Q3	$2K	Buy	+16	New	+$23.2K	﹤0.01%	4045

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cutler Group's IBIO Position: Q3 2023 in Review

Cutler Group sold out of iBio (IBIO) in Q3 2023, closing a stake of 10 shares.

Cutler Group first reported a position in IBIO in Q3 2020 and held it in 11 quarters. The position peaked at $9K in Q3 2021. 26 funds tracked by Wall St. Rank hold IBIO as of Q3 2023.

Cutler Group reported no remaining iBio position as of Q3 2023 after selling out during the quarter.
Cutler Group sold 10 iBio shares in Q3 2023.
Cutler Group first reported a position in iBio in Q3 2020 and held it in 11 quarters.
Cutler Group's iBio position peaked at $9K in Q3 2021.
26 funds tracked by Wall St. Rank held iBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.